Gazette Tracker
Gazette Tracker

Core Purpose

Notification under the proviso to Rule 54 of the Narcotic Drugs and Psychotropic Substances Rules, 1985 permitting eight named pharmaceutical manufacturers to import morphine, codeine, thebaine and their salts for use in export-bound products.

Detailed Summary

Issued by the Ministry of Finance, Department of Revenue, at New Delhi on 25 September 2023 as S.O. 4223(E), the notification exercises the proviso to Rule 54 of the Narcotic Drugs and Psychotropic Substances Rules, 1985 to permit eight manufacturers -- M/s Adcock Ingram Limited (Bangalore), M/s Rusan Pharma Ltd. (Mumbai), M/s Sanofi India Limited (Mumbai), M/s Sun Pharmaceuticals Industries Ltd. (Mumbai), M/s Verve Human Care Laboratories (Dehradun, Uttarakhand), M/s Wockhardt Limited (Mumbai), M/s Alphamed Formulations Private Limited (Medchal-Malkajgiri district, Telangana) and M/s Cipla Ltd. (Mumbai) -- to import morphine, codeine, thebaine and their salts for use in manufacturing products intended for export, subject to the procedure specified in Rule 55 and to conditions in the import certificate issued in Form No. 4A; the notification states it shall remain in force from the date of its publication until 31 December 2024, and is issued under File No. N.11012/1/2013-SO(NC-II) and signed by Mukesh Sundriyal, Under Secretary.

Full Text

6102 GI/202 3 (1) रजिस्ट्री सं. डी.एल.- 33004/99 REGD. No . D. L. -33004/99 EXTRAORDINARY PART II —Section 3 —Sub-section ( ii) PUBLISHED BY AUTHORITY (1) (2) No. 4055 ] NEW DELHI, MONDAY , SEPTEMBER 25 , 2023/ ASVINA 3, 1945 CG-DL-E-25092023-248990 MINISTRY OF FINANCE (Department of Revenue) NOTIFICATION New Delhi, the 2 5th September , 2023 S.O. 4223 (E).—In exercise of the powers conferred by the proviso to rule 54 of the Narcotic Drugs and Psychotropic Substances Rules, 1 985, the Central Government hereby notifies that the manufacturers mentioned in the Table below are permitted to import morphine, codeine, thebaine and their salts for use in manufacture of products to be exported, after following the procedure specified i n rule 55 of the said rules and subject to such conditions as may be specified in the import certificate issued in Form No. 4A annexed to the aforesaid rules, namely: - Sl.No. Name and Address of manufacturers (1) (2) 1. M/s Adcock Ingram Limited, 49 -C and D, Bommasandra Industrial Area, Anekal Taluk, Bangalore - 560099. 2. M/s Rusan Pharma Ltd., 58 -D, Government Industrial Estate, Charpok, Kandivali (W), Mumbai -400067. 3. M/s Sanofi India Limited, Sanofi House, CTB No. 117 -B, L&T Business Park, Saki Vihar Road, Powai, Mumbai -400072. 4. M/s Sun Pharmaceuticals Industries Ltd. Acme Plaza, Andheri Kurla Road, Andheri (East), Mumbai -400059. 5. M/s Verve Human Care Laboratories, Plot No. 15 -A, Pharmacity, Selaqui, Dehradun -248011 Uttrakhand. 6. M/s Wockhardt Limited, Wockhardt Towers, Bandra Kurla Complex, Mumbai -400051. 7. M/s Alphamed Formulations Private Limited, Survey No 225, Sampanbole Village, Shamirpet, Mandal, Medchal -Malkajgiri Dist., Telangana -500101. 8. M/s Cipla Ltd., Cipla House, Peninsul a Business Park, Ganpatrao Kadma Marg, Lower Parel, Mumbai - 400013. 2. This notification shall remain in force from the date of its publication in the Official Gazette till the 31st day of December, 202 4. [F. No. N.11012/1/2013 -SO(NC -II)] MUKESH SUNDRIYAL , Under Secy. Uploaded by Dte. of Printing at Government of India Press, Ring R oad, Mayapuri, New Delhi -110064 and Published by t he Controller of Publications, Delhi -110054.

Never miss important gazettes

Create a free account to save gazettes, add notes, and get email alerts for keywords you care about.

Sign Up Free